Lcn2 is also upregulated in the brain of patients affected by Alzheimer’s disease (Dekens et al., 2017), Parkinson’s disease (Kim et al., 2016), and multiple sclerosis (Al Nimer et al., 2016). This evidence concerns the gene LCN2 and Alzheimer disease.